Keros Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $30M | 764k | 39.76 |
| 2023-09-30 | $13M | 406k | 31.88 |
| 2023-06-30 | $13M | 329k | 40.18 |
| 2023-03-31 | $16M | 373k | 42.70 |
| 2022-12-31 | $20M | 424k | 48.02 |
| 2022-06-30 | $10M | 372k | 27.63 |
| 2022-03-31 | $16M | 287k | 54.38 |
| 2021-12-31 | $18M | 303k | 58.51 |
| 2021-09-30 | $11M | 274k | 39.56 |
| 2021-06-30 | $5.0M | 118k | 42.48 |
| 2021-03-31 | $7.8M | 128k | 61.04 |
| 2020-12-31 | $19M | 269k | 70.54 |
| 2020-06-30 | $5.9M | 157k | 37.51 |